184 related articles for article (PubMed ID: 24763965)
1. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
[TBL] [Abstract][Full Text] [Related]
2. Statin therapy and inflammation in patients with diabetes treated with high dose aspirin.
Chaudhary R; Bliden KP; Garg J; Mohammed N; Tantry U; Mathew D; Toth PP; Franzese C; Gesheff M; Pandya S; Gurbel P
J Diabetes Complications; 2016; 30(7):1365-70. PubMed ID: 27237049
[TBL] [Abstract][Full Text] [Related]
3. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
4. Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy.
Franzese CJ; Bliden KP; Gesheff MG; Pandya S; Guyer KE; Singla A; Tantry US; Toth PP; Gurbel PA
Am J Cardiol; 2015 May; 115(9):1204-11. PubMed ID: 25759102
[TBL] [Abstract][Full Text] [Related]
5. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
Gao F; Wang ZX; Men JL; Ren J; Wei MX
Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
[TBL] [Abstract][Full Text] [Related]
6. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
[TBL] [Abstract][Full Text] [Related]
7. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory effect of statins on urinary 11-dehydrothromboxane levels.
Alusik S; Paluch Z; Lejsková M; Adámek T
Int Angiol; 2010 Jun; 29(3):255-9. PubMed ID: 20502413
[TBL] [Abstract][Full Text] [Related]
9. Variation in thromboxane B2 concentrations in serum and plasma in patients taking regular aspirin before and after clopidogrel therapy.
Good RI; McGarrity A; Sheehan R; James TE; Miller H; Stephens J; Watkins S; McConnachie A; Goodall AH; Oldroyd KG
Platelets; 2015; 26(1):17-24. PubMed ID: 24433337
[TBL] [Abstract][Full Text] [Related]
10. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
11. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.
Carroll RC; Craft RM; Snider CC; Aligeti VR; Wortham DC
Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970
[TBL] [Abstract][Full Text] [Related]
12. Association of weight gain with coronary artery disease, inflammation and thrombogenicity.
Chaudhary R; Bliden KP; Tantry US; Mohammed N; Mathew D; Gesheff MG; Franzese CJ; Gurbel PA
J Thromb Thrombolysis; 2016 Apr; 41(3):394-403. PubMed ID: 26714821
[TBL] [Abstract][Full Text] [Related]
13. 24-hour time-dependent aspirin efficacy in patients with stable coronary artery disease.
Henry P; Vermillet A; Boval B; Guyetand C; Petroni T; Dillinger JG; Sideris G; Bal dit Sollier C; Drouet L
Thromb Haemost; 2011 Feb; 105(2):336-44. PubMed ID: 21136023
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
15. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
[TBL] [Abstract][Full Text] [Related]
16. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
Dharmasaroja PA; Sae-Lim S
J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
[TBL] [Abstract][Full Text] [Related]
17. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
18. Changes in preventive medical therapies and CV risk factors after CT angiography.
Cheezum MK; Hulten EA; Smith RM; Taylor AJ; Kircher J; Surry L; York M; Villines TC
JACC Cardiovasc Imaging; 2013 May; 6(5):574-81. PubMed ID: 23582355
[TBL] [Abstract][Full Text] [Related]
19. Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High-Risk Patients for Cardiovascular Disease.
Tacconelli S; Dovizio M; Di Francesco L; Meneguzzi A; D'Agostino I; Evangelista V; Manarini S; Capone ML; Grossi L; Porreca E; Di Febbo C; Bruno A; Ballerini P; Levantesi G; Fava C; Minuz P; Patrignani P
Clin Pharmacol Ther; 2018 Jul; 104(1):111-119. PubMed ID: 29574792
[TBL] [Abstract][Full Text] [Related]
20. Influence of race and sex on thrombogenicity in a large cohort of coronary artery disease patients.
Lev EI; Bliden KP; Jeong YH; Pandya S; Kang K; Franzese C; Tantry US; Gurbel PA
J Am Heart Assoc; 2014 Oct; 3(5):e001167. PubMed ID: 25332180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
